A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer

NCT05420948 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma
Head and Neck Neoplasms
Head Cancer
Throat Carcinoma

Interventions

DRUG: Pembrolizumab
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

University of Chicago